Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

Constitutional Delay in Growth and Puberty (CDGP) Clinical Trial

Official title: A Multi-Center, Open-Label, Observational Study of Testosterone Gel (1%) in the Treatment of Adolescent Boys With Hypogonadism

Status Completed

Clinical Trial Summary

This study is to observe efficacy and safety after T-Gel 1% treatment in delayed puberty adolescents. Subjects who complete this trial may enter a 3 month extension study (UMD-01-090E).

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Constitutional Delay in Growth and Puberty (CDGP)
• Hypogonadism
• Primary or Secondary Hypogonadism

• NCT number: NCT00193661
• Study type: Interventional
• Source: Solvay Pharmaceuticals
• Status: Completed
• Phase: Phase 2
• Start date: August 2002
• Completion date: March 2007